Skip to main content
Journal cover image

Examining Healthcare Resource Utilization (HCRU) and Costs in US Patients Diagnosed with Relapsed Acute Myeloid Leukemia (AML)

Publication ,  Conference
Tabah, A; Knoth, R; Huggar, D; Copher, RM; Cao, Z; Lipkin, C; Leblanc, TW
Published in: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
2020

Duke Scholars

Published In

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

EISSN

2152-2669

ISSN

2152-2650

Publication Date

2020

Volume

20

Start / End Page

S181 / S181

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 3201 Cardiovascular medicine and haematology
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Tabah, A., Knoth, R., Huggar, D., Copher, R. M., Cao, Z., Lipkin, C., & Leblanc, T. W. (2020). Examining Healthcare Resource Utilization (HCRU) and Costs in US Patients Diagnosed with Relapsed Acute Myeloid Leukemia (AML). In CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (Vol. 20, pp. S181–S181).
Tabah, Ashley, Russell Knoth, David Huggar, Ronda M. Copher, Zhun Cao, Craig Lipkin, and Thomas W. Leblanc. “Examining Healthcare Resource Utilization (HCRU) and Costs in US Patients Diagnosed with Relapsed Acute Myeloid Leukemia (AML).” In CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 20:S181–S181, 2020.
Tabah A, Knoth R, Huggar D, Copher RM, Cao Z, Lipkin C, et al. Examining Healthcare Resource Utilization (HCRU) and Costs in US Patients Diagnosed with Relapsed Acute Myeloid Leukemia (AML). In: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2020. p. S181–S181.
Tabah, Ashley, et al. “Examining Healthcare Resource Utilization (HCRU) and Costs in US Patients Diagnosed with Relapsed Acute Myeloid Leukemia (AML).” CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, vol. 20, 2020, pp. S181–S181.
Tabah A, Knoth R, Huggar D, Copher RM, Cao Z, Lipkin C, Leblanc TW. Examining Healthcare Resource Utilization (HCRU) and Costs in US Patients Diagnosed with Relapsed Acute Myeloid Leukemia (AML). CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. 2020. p. S181–S181.
Journal cover image

Published In

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

EISSN

2152-2669

ISSN

2152-2650

Publication Date

2020

Volume

20

Start / End Page

S181 / S181

Related Subject Headings

  • 3211 Oncology and carcinogenesis
  • 3201 Cardiovascular medicine and haematology
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences